Cicor Technologies · SIX:CICN
Cicor Technologies — ZKB Swiss Equity Conference 2024
40 slides from Cicor Technologies's conference presentation, Nov 6, 2024
Slide 1: Cicor Technologies Ltd. ZKB Swiss Equity Conference 2024
Cicor Technologies Ltd. ZKB Swiss Equity Conference 2024 November 6, 2024 Alexander Hagemann, CEO Peter Neumann, CFO
Slide 2: Disclaimer
November 6, 2024 Disclaimer The information in this presentation does not constitute an offer or invitation and may not be construed as a recommendation by us to purchase, hold or sell shares of Cicor Technologies Ltd. This information or any copy thereof may not be sent or taken to or distributed i
Slide 3: Cicor Group - Market and Business
Alexander Hagemann, CEO Cicor Group - Market and Business 3
Slide 4: Fastest growing manufacturer of advanced electronics in Europe
The Cicor Group Fastest growing manufacturer of advanced electronics in Europe 2024 Sales guidance 2024 EBITDA guidance CHF 470-510 million CHF 50-60 million Organic growth ahead of Electronic Mid-Term 10-13% margin. Top Manufacturing market profitability vs peer group HY 2024 Earnings per share HY
Slide 5: Turning ideas into advanced electronic solutions
Electronification of everything Turning ideas into advanced electronic solutions Healthcare Technology Industrial Aerospace & Defense (A&D) 24% of sales in HY 2024 33% of sales in HY 2024 24% of sales in HY 2024 Cicor helps improve Cicor is at the forefront Cicor ensures safety, global healthcare by
Slide 6: Advancing healthcare through technology
United Kingdom Hartlepool, Newport Building ofin 2023 29% of sales leading platforms in attractive markets Germany Dresden, Radeberg, Ulm, Wutha-Farnroda / Buttlar Advancing healthcare Romania through technology Arad, Bucharest China Switzerland Dongguan, Suzhou Boudry, Bronschhofen, Wangs • Develop
Slide 7: European market leader for A&D EMS
Building ofin 2023 29% of sales leading platforms in attractive markets Bedford, UK European market leader Radeberg, Germany Newport, UK Gosport, UK Ulm, Germany for A&D EMS Boudry, Switzerland Bronschhofen, Switzerland Wangs, Switzerland • Long-standing supplier of design and manufacturing services
Slide 8: Driving automation and miniaturisation in industry
United Kingdom Hartlepool, Newport Building ofin 2023 29% of sales leading platforms in attractive markets Germany Dresden, Radeberg, Ulm, Wutha-Farnroda / Buttlar Driving automation and Romania miniaturisation in industry Arad China Switzerland Dongguan, Suzhou Boudry, Bronschhofen, Wangs • Develop
Slide 9: Leadership – step by step
The Cicor Group Leadership – step by step European market position UK market position # 10 #1 Pro-forma 2024, from # 28 in 2021 From acquisitions made 2021- 2024 Position in Aerospace & Defense Position in Healthcare Technology #1 #4 In Europe - expanding the lead vs. In Europe - working towards #2
Slide 10: Cicor with strongest resilience and highest growth
Net Sales Q1-Q3/2024 and growth comparison amongst listed European peers Cicor with strongest resilience and highest growth [EUR mln] Q1-Q3/2023 Q1-Q3/2024 800 700 600 500 400 300 200 100 0 Growth -17% -16% +21% +13% -11% -5% Organic -17% -16% -4% -6% -11% -20% 12
Slide 11: Cicor 2028
Alexander Hagemann, CEO Cicor 2028 13
Slide 12: Cicor 2028 – creating together: Vision Statement
Cicor 2028 – creating together Vision Statement We are the leading pan-European electronics design and manufacturing partner for healthcare technology, aerospace/- defense and industrial, recognised as an employer of choice, committed to operating sustainably 15
Slide 13: 17
17
Slide 14: Expect healthy market growth during strategy period
The European EMS market Expect healthy market growth during strategy period • European EMS market expected to grow at 6.5% CAGR from 2023 to 2028 • Normalisation of market in 2025 after destocking in 2024 • Unchanged longterm trends of nearshoring and increased outsourcing Market driving factors: •
Slide 15: A comprehensive strategy with clear implementation plan
Core strategy initiatives towards delivering on 2028 objectives A comprehensive strategy with clear implementation plan Focus on high growth Transformation into a Business excellence AS Division as high verticals true creator of products driving performance tech differentiator Accelerate growth with
Slide 16: Market Leadership - How we outgrow the market
Market Leadership - How we outgrow the market Cicor focuses on sub-verticals with high growth and margins Bubble size: EMEA market size 2023 in MCHF High > 15% Cicor addressed sub-verticals Mid 10% - 15% Cicor EBITDA 2023 Low < 10% -2.0% 2.0% 6.0% 10.0% 14.0% Expected Market CAGR 2023 - 2028 Source:
Slide 17: Transforming Cicor into a true product creation company
Strengthening the engineering portion of Cicor Transforming Cicor into a true product creation company customer loyalty & pricing power Business case & use specification Research and product After sales development New and lifetime Device Distribution services product Electronics assembly introducti
Slide 18: Cicor - Operations Strategy
Cicor - Operations Strategy Business excellence driving results VISION MISSION The Business Excellence Model is a framework that combines Manufacturing Engineering Compliance Information Customer vision, mission and values Sourcing Finance People with key value-add performance categories and support
Slide 19: Rationale for M&A – the external market view
Rationale for M&A – the external market view The European EMS market is highly fragmented and growing, pre-destined for consolidation Fragmented market Growing market Customer loyalty Economies of scale 1,700 EMS € 25 billion In Europe, consolidation Adressed market (2023), has just begun: 44% of to
Slide 20: M&A
cicor Peter Neumann, CFO M&A 24
Slide 21: Proven path to value creation
Experience from past acquisitions Proven path to value creation Highly selective which opportunities are pursued Fast realization of Cicor is often the cash and cost acquirer of choice synergies Market share gains Ability to acquire at post-closing moderate multiples Efficient and trusted M&A proces
Slide 22: Strong Financial foundation for M&A
Value creation through M&A Strong Financial foundation for M&A • 2023 Refinancing provides flexibility for future operational and acquisition requirements at attractive conditions. • Interests linked to SARON with margin grid depending on Cicor leverage (net debt / EBITDA). • Net debt / EBITDA ratio
Slide 23: Clear strategy to establish Cicor as the pan-European leader
Value creation through M&A Clear strategy to establish Cicor as the pan-European leader for A&D, Medical and High-End Industrial Electronic solutions Driving industry consolidation in Europe with a focus on well-managed manufacturers and highly attractive customer portfolios within Cicor’s core busi
Slide 24: Strong deal flow, selective deal criteria and high success rate
Value creation through M&A Strong deal flow, selective deal criteria and high success rate Since announcement of our inorganic growth strategy in mid-2021 … >1’700 EMS Thin film business of companies >100 deals reviewed 16 NBOs issued 9 deals under exclusivity 7 deals closed in Europe Key insights:
Slide 25: Cicor often acquirer of choice for sellers
Value creation through M&A Cicor often acquirer of choice for sellers Long-term industrial vision Alignment of Trust interests Swissness M&A track record Collaboration with Industry expertise local management Cicor’s M&A edge Cicor has build up a reputation as a long-term oriented, trust-worthy stra
Slide 26: Cicor follows a disciplined, streamlined and proven M&A process
Value creation through M&A Cicor follows a disciplined, streamlined and proven M&A process Deal flow management Deal execution Post-Merger Integration (PMI) • Extremely selective in initial target • Financial, Tax & Legal due • Execution of PMI plan within 3-6 selection. diligence with external expe
Slide 27: Cicor employs a comprehensive PMI approach
Value creation through M&A Cicor employs a comprehensive PMI approach, ensuring a solid foundation to leverage synergies across all business activities Cicor PMI* Pillars Main areas of synergy • Activities core to our business and close to our customers Engineering • Where most potential synergies S
Slide 28: Cicor's acquisitions deliver consistent and excellent results
Value creation through M&A Cicor’s acquisitions deliver consistent and excellent results • Acquired CHF 208 million revenue (LTM pre-closing) with 7 acquisitions (CHF 95 Million excl. three 2024 acquisitions). Growth acceleration • Cicor is delivering strong revenue synergies. 2024 revenue of acquir
Slide 29: Consistent Revenue Performance and Synergies
Value creation through M&A Consistent Revenue Performance and Synergies • 2024 revenue of acquired companies in Revenue 2024 outlook compared to LTM pre-Aquisition in local currency local currency at 16% above pre-M&A LTM performance (+30% excluding three 2024 acquisitions). 120% 113% • All acquisit
Slide 30: Consistent EBITDA Performance
Value creation through M&A Consistent EBITDA Performance • 2024 EBITDA of acquired companies in EBITDA 2024 outlook compared to LTM pre-Aquisition in local currency local currency 40% above pre-LTM EBITDA (41% excluding three 2024 acquisitions). 200% 173% • All acquisitions perform strong in terms o
Slide 31: Consistent FCF Delivery to recovery of net M&A cash outlay
Value creation through M&A Consistent FCF Delivery to recovery of net M&A cash outlay Cumulative Free Cash Flow in % of Cash outlay for acquisition • M&A net cash outlay expected to be recovered via FCF delivery of acquired companies in 5-7 50% years. 46% 45% 44% • For 7 acquisitions 35% of net cash
Slide 32: M&A Summary - Cicor's unique position to create value
Value creation through M&A M&A Summary - Cicor’s unique position to create value Strong financial foundation Attractive external market with existing credit lines for an inorganic growth strategy Cicor’s recipe Proven track-record & expertise for M&A Focus on known core business of delivering succes
Slide 33: Mid-term Targets
Peter Neumann, CFO Mid-term Targets 37
Slide 34: Financial Mid-Term Objectives for 2028
Financial Mid-Term Objectives for 2028 Creating together: Establishing the pan-European leader Organic Growth Revenue Profitability Other EBIT >1’000 ROIC 1) 7 - 10% 7 – 10% >15% Net Debt / EBITDA p.A. million EBITDA <2.75 Capex 10 – 13% CHF 2.5 – 3.0% • Gaining market share through focus on strateg
Slide 35: Summary and Outlook
Alexander Hagemann, CEO Summary and Outlook 39
Slide 36: Resilience and continued growth
Outlook 2024 Resilience and continued growth • Organic growth in the first nine months slightly negative but significantly outperforming the market – expect order intake and sales to continue recovery in Q4/2024 • Very satisfying progress in integrating newly acquired companies, especially on profit
Slide 37: Cicor – an asset for your portfolio
Outlook 2024 Cicor – an asset for your portfolio • Market with longterm growth driven by megatrends of electronification‚ outsourcing and nearshoring • Strategy 2028 targeting the most profitable segments of the market: Healthcare Technology, Aerospace & Defense, Industrial • Establishing strong and
Slide 38: Analysts
Financial Research Analysts Kepler Cheuvreux Research Partners Zürcher Kantonalbank Patrick Steiner Reto Huber Bernd Laux psteiner@keplercheuvreux.com reto.huber@researchpartners.ch bernd.laux@zkb.ch +43 (1) 20 577 383 +41 44 533 40 30 +41 44 292 37 23 Baader Helvea mwb Research Zana Mamelli Alexand
Slide 39: Contacts
Investor Relations Contacts Alexander Hagemann Peter Neumann Michael Götti CEO CFO VP Corporate Marketing & Communications Cicor Management AG, Gebenloostrasse 15, 9552 Bronschhofen, Switzerland investor@cicor.com | +41 71 913 73 00 43
Slide 40: Thank You
Thank You cicor.com Cicor Group @cicor.group
Cicor Technologies — ZKB Swiss Equity Conference 2024 on 6ix